Ziad Zawaideh
Family Medicine · Omaha, NENPI 1295721546
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 213 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,081 and has fallen 98.4% since, to $32 in 2023. Among family medicine clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 213 payments — averaging $21.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- AbbVie$517
- Bayer$327
- Johnson & Johnson$318
- Mannkind Corporation$291
- Amgen$291
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,559100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 13 | $1,004 |
| AbbVie(2 entities) | 26 | $517 |
| Bayer | 7 | $327 |
| Johnson & Johnson(2 entities) | 12 | $318 |
| Mannkind Corporation | 15 | $291 |
| Amgen(2 entities) | 21 | $291 |
| Novo Nordisk | 10 | $263 |
| Lilly USA, LLC | 18 | $236 |
| Novartis | 7 | $130 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $129 |
| Pfizer | 8 | $125 |
| Otsuka America Pharmaceutical, Inc. | 5 | $100 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $85 |
| Boehringer Ingelheim | 5 | $75 |
| GSK | 6 | $75 |
| Sunovion Pharmaceuticals Inc. | 10 | $67 |
| Sanofi-aventis U.S. LLC | 4 | $56 |
| Antares Pharma, Inc. | 3 | $50 |
| Zealand Pharma US, Inc. | 3 | $49 |
| Genentech USA, Inc. | 3 | $49 |
| Amarin Pharma, Inc. | 3 | $48 |
| Collegium Pharmaceutical, Inc. | 3 | $40 |
| Kowa Pharmaceuticals America, Inc. | 3 | $38 |
| Merck | 3 | $36 |
| Eisai Inc. | 2 | $26 |
| Abbott | 1 | $22 |
| Lundbeck LLC | 1 | $22 |
| Almatica Pharma LLC | 1 | $21 |
| Lifescan, Inc. | 1 | $17 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Bristol Myers Squibb | 1 | $14 |
| Mayne Pharma Commercial LLC | 1 | $13 |
| Promius Pharma LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,559 in reported general payments places this provider in the 90th percentile of 981 family medicine providers in Nebraska.
Other family medicine in Omaha
- Gerard StanleyOmaha$50K
- Yongge LiuOmaha$15K
- M DadaOmaha$14K
- Christopher ConnollyOmaha$12K
- Paul VanaOmaha$12K
- Stephen TetraultOmaha$11K
- James RamigOmaha$11K
- Jeffrey RappOmaha$10K
- Christine Carlson RahnOmaha$10K
- Joseph DumbaOmaha$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.